Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 10, 2008
IVIVC of controlled release formulations: physiological-dynamical reasons for their failure
A Dokoumetzidis, P Macheras
Pharmaceutica Acta Helvetiae
|
January 1, 1983
The bioequivalence factor
P Macheras, A Rosen
The Journal of Pharmacy and Pharmacology
|
March 1, 1985
Effect of protein on the absorption of phenytoin through everted gut preparations
A Rosen, P Macheras
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 23, 2000
On the use of partial AUC as an early exposure metric
A Dokoumetzidis, P Macheras
Pharmaceutical Research
|
April 6, 2000
On the heterogeneity of drug dissolution and release
P Macheras, A Dokoumetzidis
Die Pharmazie
|
May 1, 1984
GLC analysis following oxidation of phenytoin. An inexpensive method for routine determination of the drug in plasma
P Macheras, A Rosen
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 21, 2022
Columbus' egg: Oral drugs are absorbed in finite time
P Macheras, A A Tsekouras
Journal of Pharmaceutical Sciences
|
May 7, 1999
An alternative method for the estimation of the terminal slope when a few data points are available
A Dokoumetzidis, A Iliadis, P Macheras
Journal of Pharmacokinetics and Pharmacodynamics
|
January 5, 2002
A stochastic model describes the heterogeneous pharmacokinetics of cyclosporin
L Claret, A Iliadis, P Macheras
International Journal of Pharmaceutics
|
April 4, 2003
The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis
E Rinaki, G Valsami, P Macheras
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 10, 2008
IVIVC of controlled release formulations: physiological-dynamical reasons for their failure
A Dokoumetzidis, P Macheras
Pharmaceutica Acta Helvetiae
|
January 1, 1983
The bioequivalence factor
P Macheras, A Rosen
The Journal of Pharmacy and Pharmacology
|
March 1, 1985
Effect of protein on the absorption of phenytoin through everted gut preparations
A Rosen, P Macheras
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 23, 2000
On the use of partial AUC as an early exposure metric
A Dokoumetzidis, P Macheras
Pharmaceutical Research
|
April 6, 2000
On the heterogeneity of drug dissolution and release
P Macheras, A Dokoumetzidis
Die Pharmazie
|
May 1, 1984
GLC analysis following oxidation of phenytoin. An inexpensive method for routine determination of the drug in plasma
P Macheras, A Rosen
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 21, 2022
Columbus' egg: Oral drugs are absorbed in finite time
P Macheras, A A Tsekouras
Journal of Pharmaceutical Sciences
|
May 7, 1999
An alternative method for the estimation of the terminal slope when a few data points are available
A Dokoumetzidis, A Iliadis, P Macheras
Journal of Pharmacokinetics and Pharmacodynamics
|
January 5, 2002
A stochastic model describes the heterogeneous pharmacokinetics of cyclosporin
L Claret, A Iliadis, P Macheras
International Journal of Pharmaceutics
|
April 4, 2003
The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis
E Rinaki, G Valsami, P Macheras
Page
of 6